Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| adipose | 3 studies | 26% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 95% | 46558.97 | 436 / 459 | 82% | 29.17 | 915 / 1118 |
| liver | 76% | 1613.13 | 171 / 226 | 76% | 6.12 | 310 / 406 |
| adipose | 100% | 68379.84 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| brain | 11% | 144.53 | 291 / 2642 | 77% | 4.72 | 540 / 705 |
| prostate | 4% | 93.20 | 9 / 245 | 64% | 1.67 | 323 / 502 |
| pancreas | 11% | 159.06 | 35 / 328 | 44% | 6.45 | 79 / 178 |
| thymus | 18% | 476.35 | 116 / 653 | 29% | 0.96 | 175 / 605 |
| skin | 28% | 967.94 | 515 / 1809 | 16% | 1.55 | 76 / 472 |
| bladder | 19% | 597.48 | 4 / 21 | 23% | 1.90 | 116 / 504 |
| intestine | 18% | 707.57 | 175 / 966 | 16% | 1.76 | 85 / 527 |
| adrenal gland | 20% | 515.47 | 51 / 258 | 14% | 1.26 | 33 / 230 |
| kidney | 2% | 245.73 | 2 / 89 | 31% | 1.10 | 280 / 901 |
| ovary | 1% | 11.31 | 2 / 180 | 32% | 2.66 | 137 / 430 |
| stomach | 8% | 413.58 | 28 / 359 | 20% | 2.71 | 56 / 286 |
| muscle | 23% | 375.71 | 184 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 20% | 2282.32 | 266 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 9% | 318.68 | 131 / 1445 | 8% | 0.15 | 15 / 183 |
| heart | 15% | 445.09 | 132 / 861 | 0% | 0 | 0 / 0 |
| lung | 0% | 0 | 0 / 578 | 9% | 0.50 | 99 / 1155 |
| uterus | 1% | 4.98 | 1 / 170 | 8% | 1.27 | 35 / 459 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.17 | 2 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.06 | 1 / 45 |
| peripheral blood | 0% | 6.19 | 3 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006629 | Biological process | lipid metabolic process |
| GO_0070417 | Biological process | cellular response to cold |
| GO_0016042 | Biological process | lipid catabolic process |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005829 | Cellular component | cytosol |
| GO_0005811 | Cellular component | lipid droplet |
| GO_0005515 | Molecular function | protein binding |
| GO_0008289 | Molecular function | lipid binding |
| Gene name | PLIN1 |
| Protein name | Perilipin-1 (Lipid droplet-associated protein) Perilipin 1 |
| Synonyms | PLIN PERI |
| Description | FUNCTION: Modulator of adipocyte lipid metabolism. Coats lipid storage droplets to protect them from breakdown by hormone-sensitive lipase (HSL). Its absence may result in leanness. Plays a role in unilocular lipid droplet formation by activating CIDEC. Their interaction promotes lipid droplet enlargement and directional net neutral lipid transfer. May modulate lipolysis and triglyceride levels. . |
| Accessions | H0YM16 O60240 ENST00000560330.1 ENST00000430628.2 ENST00000300055.10 |
